American Century Companies Inc Athira Pharma, Inc. Transaction History

American Century Companies Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$1.92 - $2.71 $6,399 - $9,032	3,333 Added 9.36%	38,940 $103,000
Q1 2024 May 14, 2024	BUY	$2.24 - $4.15 $45,557 - $84,402	20,338 Added 133.2%	35,607 $97,000
Q4 2023 Feb 13, 2024	BUY	$1.39 - $2.46 $21,223 - $37,561	15,269 New	15,269 $37,000
Q3 2023 Nov 13, 2023	BUY	$1.9 - $3.16 $29,011 - $48,250	15,269 New	15,269 $30,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $21.9M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.